معرفی
Collin Heer is an Associate Research Scientist in the Department of Therapeutic Radiology at Yale School of Medicine, Yale University. He holds a BS in Biochemistry and Biology from Clarke University (2015) and a PhD in Free Radical and Radiation Biology from the University of Iowa (2021). His postdoctoral training at Yale (2025) further solidified his expertise in radiation biology and cancer therapy.
Dr. Heer’s research focuses on mitochondrial metabolism, NAD+ signaling in cancer and neuroinflammation, and the development of novel therapies targeting metabolic dysfunctions. His work bridges molecular mechanisms with translational applications, including radiation sensitizers, antioxidant therapies, and CRISPR-based gene editing.
His publications highlight contributions to understanding NAD+ metabolism in viral infections, synergistic effects of radiation with drugs like avasopasem, and mitochondrial dysfunction’s role in cancer progression. He collaborates with the Bindra Lab, advancing studies on tumor ablation strategies and metabolic pathways.
While no formal trainees are listed, his research aligns with Yale Cancer Center initiatives. He has presented findings at conferences like AACR25. His work emphasizes actionable insights for enhancing cancer therapies through metabolic and redox biology principles.
.jpg)
